Summary & Overview
CPT 11719: Trimming of Nondystrophic Nails, Any Number
CPT 11719 denotes trimming of nondystrophic nails, any number, a basic podiatric procedure commonly provided in outpatient office settings. Nationally, this code is used to document routine nail care when nails are structurally normal (nondystrophic) and to distinguish simple trimming from debridement or more complex nail procedures. Its clear documentation supports appropriate coding, claim submission, and distinction from related services such as nail debridement or surgical nail interventions.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of code use, typical clinical contexts where trimming of nondystrophic nails is reported, and comparisons to related CPT codes that reflect more intensive nail procedures. The publication outlines common billing considerations, likely sites of service, and the role of this code in payer policy frameworks without offering clinical guidance.
This summary is designed to inform billing staff, coding professionals, and policy analysts about the purpose and practical application of CPT 11719, where it fits in the spectrum of podiatric nail services, and what to expect in payer coverage language. Data not available in the input is noted where specific policy details, reimbursement rates, or service-line metadata are not provided.
CPT Code Overview
CPT 11719 describes trimming of nondystrophic nails, any number. This procedure is categorized under Podiatry / Surgical Procedures on the Nails and denotes professional nail care limited to trimming of nails that are not dystrophic. The typical setting for this service is the office (POS 11).
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to a podiatry office (POS 11) with thickened, overgrown, or otherwise nondystrophic toenails causing discomfort, difficulty with footwear, or hygiene concerns. The clinician (podiatrist) confirms the nails are nondystrophic on inspection and performs routine nail trimming (no surgical nail avulsion or extensive debridement) using clippers or a nail file. The workflow: triage and history, focused foot and nail exam, identification of nondystrophic nail changes, informed consent for routine nail care, performance of 11719 trimming of nails, post-procedure documentation of nails treated and findings, and coding/billing with applicable modifier(s) documenting any Class A/B/C findings when required by payer policy.
Coding Specifications
Modifiers
-
Q7: Use when there is One (1) Class A finding. -
Q8: Use when there are Two (2) Class B findings. -
Q9: Use when there is One (1) Class B finding and Two (2) Class C findings.
Provider taxonomies
-
213E00000X: Podiatrist — general podiatric practitioner who provides foot and ankle care including routine nail procedures. -
213ES0103X: Podiatrist, Foot & Ankle Surgery — podiatrist with a surgical focus who may perform more advanced nail or surgical procedures. -
213EG0000X: Podiatrist, General Practice — podiatrist providing general foot care including routine nail trimming and non-surgical interventions.
Related Diagnoses
-
B35.1— Tinea unguium (dermatophytosis of nail)- Relevance: Fungal infection can cause nail thickening or changes that may prompt routine trimming or debridement for symptomatic relief and hygiene.
-
L60.2— Onycholysis- Relevance: Nail plate separation may lead to debris or nail irregularity addressed during trimming.
-
L60.3— Onychauxis- Relevance: Nail thickening (onychauxis) can necessitate trimming to reduce discomfort or pressure.
-
A30.0— Indeterminate leprosy- Relevance: Leprosy can produce peripheral nerve and skin changes affecting nails; routine nail care may be part of supportive management.
-
A30.1— Tuberculoid leprosy- Relevance: See above; nail care may be necessary due to neuropathic or trophic changes.
-
A30.2— Borderline tuberculoid leprosy- Relevance: See above.
-
A30.3— Borderline leprosy- Relevance: See above.
-
A30.4— Borderline lepromatous leprosy- Relevance: See above.
-
A30.5— Lepromatous leprosy- Relevance: See above.
-
A30.8— Other forms of leprosy- Relevance: See above.
-
A30.9— Leprosy, unspecified- Relevance: See above.
-
A52.10— Symptomatic neurosyphilis, unspecified- Relevance: Neurosyphilis can cause neuropathic changes affecting feet and nails; routine nail care may be indicated.
-
A52.11— Tabes dorsalis- Relevance: Tabes dorsalis can produce sensory loss and foot changes requiring supportive nail care.
-
A52.15— Late syphilitic neuropathy- Relevance: Neuropathy-related nail issues may prompt routine trimming.
-
A52.16— Charcot's arthropathy (tabetic)- Relevance: Foot deformity and neuropathy increase nail and skin care needs; routine trimming may be provided.
-
A52.17— General paresis- Relevance: Neurologic compromise may affect foot care and necessitate regular nail management.
-
A52.3— Neurosyphilis, unspecified- Relevance: See related neuropathic implications above.
-
D51.0— Vitamin B12 deficiency anemia due to intrinsic factor deficiency- Relevance: Neuropathy from B12 deficiency can affect foot sensation and nail care needs.
-
D53.1— Other megaloblastic anemias, not elsewhere classified- Relevance: Megaloblastic processes may be associated with nail changes or neuropathy influencing nail care.
-
D68.8— Other specified coagulation defects- Relevance: Coagulation defects affect bleeding risk during nail procedures and are relevant to procedure planning.
-
E08.42— Diabetes mellitus due to underlying condition with diabetic polyneuropathy- Relevance: Diabetic neuropathy increases risk of foot complications and makes routine nail trimming an important part of foot care.
-
E09.40— Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified- Relevance: Neuropathy from drug-induced diabetes can necessitate routine nail care.
-
E09.42— Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy- Relevance: See above; neuropathic foot changes influence the need for nail trimming.
Related CPT Codes
-
11720— Debridement of nail(s) by any method(s); 1 to 5- Clinical relation:
11720is used when active debridement (removal of subungual debris, hyperkeratotic tissue, or fungal material) is performed rather than simple trimming; may be an alternative if debridement is clinically indicated.
- Clinical relation:
-
11721— Trimming or debridement of nails, any number (multiple)- Clinical relation:
11721represents an alternate code for trimming or debridement when billed as a multiple procedure; may be used in different payer policies or when multiple nails require treatment.
- Clinical relation:
Common usage notes: 11719 is for trimming of nondystrophic nails (any number). 11720 is used when debridement is performed for 1–5 nails. 11721 may be used for trimming or debridement of nails when payer rules or procedure context requires the multiple procedure code. These codes can be alternatives depending on the clinical procedure performed and payer-specific coding guidance.
National Reimbursement Benchmarks
Medicare's national mean allowed rate for 11719 ($14.83) sits below the BUCA (average commercial) mean ($16.85). The gap between Medicare and the average commercial benchmark represented by BUCA is modest in absolute dollars, with commercial means generally higher than Medicare.
Rate dispersion varies across payers. UnitedHealth Group and Cigna show the widest interquartile ranges (UHC P75−P25 = $11.00; Cigna P75−P25 = $10.17), indicating greater variability in allowed rates, while Medicare is the tightest (P75−P25 = $1.00), reflecting very consistent rates across localities. Aetna and Blue Cross Blue Shield have moderate dispersion, and BUCA's spread is intermediate.
The table and chart below present the full breakdown of mean rates and key percentiles for each national payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.